Where are you?
  • Austria
  • Belgium
  • Chile
  • Denmark
  • Finland
  • France
  • Germany
  • Guernsey
  • Ireland
  • Italy
  • Jersey
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Portugal
  • Singapore
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom
  • Rest of World
It looks like you’re in
Not your location?
And finally, please confirm the following details
I’m {role} in {country} and I agree to comply with the terms of the website.
You are viewing as from Change

Pieran Maru

Fund Manager, Global Equities team

About Pieran

Pieran Maru is a Fund Manager in the Global Equities team. Pieran joined Liontrust in 2024 from GAM where he covered software and hardware companies in GAM’s Global Equity team. Pieran initially joined GAM in 2017, before moving to the Global Equity team in 2021. Pieran holds a BA in Materials Science from the University of Oxford, the Investment Management Certificate (IMC), Certificate in ESG Investing and has passed CFA Exam Level 1.

Meet the tea

Latest insights

See all related
David Goodman David Goodman
"AI is not going to take your job" — but people who know how to use it might David Goodman explains why the narrative that “AI is coming for your job” misses the point and it is rather about humans using machines to outcompete one another.
icon 29 January 2025
AI handshake
Pieran Maru Pieran Maru
Beyond classical: Quantum computing's leap Quantum computing offers the promise of significant advancements in AI and machine learning across a wide range of fields. Pieran Maru analyses the potential impact of quantum computing and the opportunities for investors, as well as the possible challenges.
icon 29 January 2025
Quantum computer
Lionesses Multiple authors
DeepSeek – what just happened in AI?
icon 27 January 2025
David Goodman David Goodman
Poker and active investing David Goodman looks at how active investing and poker share similarities in psychology, strategy and risk
icon 24 October 2024
Bear
Pieran Maru Pieran Maru
AI Agents: Are they the new workforce? Pieran Maru explains what AI Agents are, de-bunks some misconceptions and discusses who the winners and losers might be from their development
icon 24 October 2024
AI agents workforce
Kevin Kruczynski Kevin Kruczynski
The US prescription drug market is ripe for disruption Research reveals that US drug prices are nearly 2.8 times higher than the average in comparable countries primarily due to patent protection and the absence of centralised negotiation capabilities. Kevin Krucynski discusses how to invest in potential disruptors in the market
icon 24 October 2024
US prescription